Результаты поиска - Shanthakumar Tyavanagimatt

  • Отображение 1 - 9 результаты of 9
Отмена результатов
  1. 1
    Development of ST-246® for Treatment of Poxvirus Infections

    Development of ST-246® for Treatment of Poxvirus Infections по Robert Jordan, Janet M. Leeds, Shanthakumar Tyavanagimatt, Dennis E. Hruby

    Опубликовано 2010
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor

    Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor по Robert Jordan, Deborah Tien, Tové C. Bolken, Kevin F. Jones, Shanthakumar Tyavanagimatt, Josef Strasser, Annie Frimm, Michael L. Corrado, Phoebe G. Strome, Dennis E. Hruby

    Опубликовано 2008
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    A potent Lassa virus antiviral targets an arenavirus virulence determinant

    A potent Lassa virus antiviral targets an arenavirus virulence determinant по Ikenna G. Madu, Megan Files, Dima Gharaibeh, Amy L. Moore, Kie-Hoon Jung, Brian B. Gowen, Dongcheng Dai, Kevin F. Jones, Shanthakumar Tyavanagimatt, James R. Burgeson, Marcus J. Korth, Kristin Bedard, Shawn P. Iadonato, Sean M. Amberg

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein

    A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein по Chelsea M. Byrd, Dongcheng Dai, Douglas W. Grosenbach, Aklile Berhanu, Kevin F. Jones, Kara B. Cardwell, Christine A. Schneider, Kristin A. Wineinger, Jessica Pagé, Chris Harver, Eric Stavale, Shanthakumar Tyavanagimatt, Melialani A. Stone, Ralf Bartenschlager, Pietro Scaturro, Dennis E. Hruby, Robert Jordan

    Опубликовано 2012
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers

    Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers по Jarasvech Chinsangaram, Kady M. Honeychurch, Shanthakumar Tyavanagimatt, Janet M. Leeds, Tové C. Bolken, Kevin F. Jones, Robert Jordan, Thomas Marbury, Jon Ruckle, Denis Mee-Lee, Eric A. Ross, Israel Lichtenstein, Margaret Pickens, Michael L. Corrado, Jean Μ. Clarke, Annie Frimm, Dennis E. Hruby

    Опубликовано 2012
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis

    Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis по Stephen T. Oh, Ruben A. Mesa, Claire Harrison, Prithviraj Bose, Aaron T. Gerds, Vikas Gupta, Bart L. Scott, Jean‐Jacques Kiladjian, Alessandro Lucchesi, Tim Kong, Sarah Buckley, Shanthakumar Tyavanagimatt, Bryan Harder, Karisse Roman‐Torres, Jennifer A. Smith, Adam R. Craig, John Mascarenhas, Srđan Verstovšek

    Опубликовано 2023
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification

    ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification по Robert Jordan, Arthur J. Goff, Annie Frimm, Michael L. Corrado, Lisa E. Hensley, Chelsea M. Byrd, Eric M. Mucker, Josh Shamblin, Tové C. Bolken, Carly Wlazlowski, Wendy Johnson, Jennifer Chapman, Nancy Twenhafel, Shanthakumar Tyavanagimatt, Adams Amantana, Jarasvech Chinsangaram, Dennis E. Hruby, John W. Huggins

    Опубликовано 2009
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase

    Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase по Chelsea M. Byrd, Douglas W. Grosenbach, Aklile Berhanu, Dongcheng Dai, Kevin F. Jones, Kara B. Cardwell, Christine A. Schneider, Guang Yang, Shanthakumar Tyavanagimatt, Chris Harver, Kristin A. Wineinger, Jessica Pagé, Eric Stavale, Melialani A. Stone, Kathleen Fuller, Candace Lovejoy, Janet M. Leeds, Dennis E. Hruby, Robert Jordan

    Опубликовано 2013
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis

    Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis по Aaron T. Gerds, Michael R. Savona, Bart L. Scott, Moshe Talpaz, Miklós Egyed, Claire Harrison, Abdulraheem Yacoub, Alessandro M. Vannucchi, Adam J. Mead, Jean‐Jacques Kiladjian, Jennifer O’Sullivan, Valentín García‐Gutiérrez, Prithviraj Bose, Raajit K. Rampal, Carole B. Miller, Jeanne Palmer, Stephen T. Oh, Sarah Buckley, Diane R. Mould, Kaori Ito, Shanthakumar Tyavanagimatt, Jennifer A. Smith, Karisse Roman‐Torres, Sri Devineni, Adam R. Craig, John Mascarenhas

    Опубликовано 2020
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: